The future of syndromic testing with QIAstat-Dx


The advanced capabilities of the QIAstat-Dx allows for a much broader range of applications beyond currently available systems and drive the development of multiplex testing into various therapeutic areas.

  • Unmatched target and application versatility

    The only syndromic platform based on real-time PCR that can process up to 48 targets

  • Flexible approach to result customization

    Allowing the development of more tailored approaches to analysis and reporting

  • Integration of real-time PCR technology

    Allowing for Ct values and amplification curves

  • Powerful QIAGEN technology capabilities

    Opening up opportunities in a broad range of application areas not possible with currently available system

Learn how your laboratory can benefit from QIAstat-Dx

Social Sharing